Claudia Trautwein
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Nanoplatforms for cancer theranostics, Immune cells in cancer, T-cell and B-cell Immunology
Most-Cited Works
- → Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival(2012)780 cited
- → Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy(2012)200 cited
- → Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy(2012)21 cited
- → Identification of Naturally Processed Hepatitis C Virus-Derived Major Histocompatibility Complex Class I Ligands(2012)19 cited
- → RIPK1 suppresses a TRAF2-dependent pathway to liver cancer(2017)15 cited
- → Abstract 2396: IMA950: A novel multi-peptide cancer vaccine for treatment of glioblastoma(2010)5 cited
- → Abstract 5365: Prolonged survival of patients with advanced renal cancer responding to multi-peptide vaccine IMA901 after single-dose cyclophosphamide(2012)1 cited
- Deep Learning for diagnosis of microsatellite instable and Epstein-Barr-Virus-associated gastric cancer(2021)
- → Erhöhte miR-122 Serumkonzentration stellen einen Biomarker für einen Leberschaden bei kritisch kranken Patienten dar(2014)
- → Die gewebsspezifische Rolle des Farnesoid Rezeptors X (FXR) in der Darm-Leber-Achse und dessen Einfluss auf chronisch-cholestatische Lebererkrankungen(2024)